Andrew Wendahl, DO
Pain Medicine · Denver, CONPI 1447631361
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,444 of the $3,983 with a category attached, or 61.4%. 18 manufacturers reported payments, led by Boston Scientific at 53.4% of the total. Reporting peaked in 2019 at $1,640 and has fallen 86.9% since, to $214 in 2025.
Across 49 payments — averaging $81.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Medtronic$510
- Nevro Corp.$409
- BD$214
- Avanos Medical$143
- Biohaven Pharmaceuticals, Inc.$74
- plus $506 from 12 others
What the payments were for
- Travel & lodging$1,53939%
- Food & beverage$2,44461%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $2,126 |
| Medtronic | 5 | $510 |
| Nevro Corp. | 4 | $409 |
| BD | 1 | $214 |
| Avanos Medical | 1 | $143 |
| Biohaven Pharmaceuticals, Inc. | 3 | $74 |
| SPR Therapeutics, Inc | 2 | $71 |
| Amgen | 2 | $68 |
| Abbott | 2 | $56 |
| Edwards Lifesciences | 1 | $55 |
| Biodelivery Sciences International, Inc. | 3 | $48 |
| AbbVie | 2 | $48 |
| Merck | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Stryker | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Vertos Medical, Inc. | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,983 in reported general payments places this provider in the 60th percentile of 96 pain medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in Denver
- Christopher D AmbrosiaDenver$2K
- Robert MoghimGolden$273K
- Jack RentzGreenwood Village$264K
- Donald BernardiniEnglewood$102K
- Haley BurkeAurora$55K
- Amar PatelThornton$47K
- David ColumbusLoveland$30K
- Matthew PouliotFort Collins$26K
- Justin MerkowEnglewood$24K
- Daniel FeldmanBroomfield$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.